Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 63559 [2020-22324]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 196 / Thursday, October 8, 2020 / Notices
For regulatory reporting purposes, the
Board is proposing similar treatment for
last-of-layer FVHBAs on FR Y–9C
Schedule HC–C, Loans and Lease
Financing Receivables, and Schedule
HC–B, Securities. As such, following the
FASB’s adoption of a final last-of-layer
hedge accounting standard, the
instructions for Schedule HC–C, item
11, ‘‘LESS: Any unearned income on
loans reflected in items 1–9 above,’’
would be revised to explicitly state that
last-of-layer FVHBAs associated with
the loans reported in Schedule HC–C,
should be included in this item.
In addition, the Board is proposing on
Schedule HC–B, Securities, to rename
existing item 7, ‘‘Investments in mutual
funds and other equity securities with
readily determinable fair values,’’ as
‘‘Unallocated last-of-layer fair value
hedge basis adjustments.’’ HCs would
report amounts for last-of-layer FVHBAs
on AFS debt securities only in item 7,
column C, ‘‘Available-for-sale:
Amortized Cost.’’ Only a small number
of HCs that have not have yet adopted
ASU 2016–01, which includes
provisions governing the accounting for
investments in equity securities,
continue to report amounts in item 7.
Because all institutions are required to
adopt ASU 2016–01 for FR Y–9C
purposes by the December 31, 2020,
report date, the Board had previously
determined that existing item 7 in
Schedule HC–B would no longer be
applicable to institutions for reporting
purposes and could be removed as of
that report date.20 For these reasons, the
Board is proposing to redesignate
existing item 7, column C, on Schedule
HC–B, as a new item for reporting
unallocated FVHBAs applicable to AFS
debt securities following the FASB’s
adoption of a final last-of-layer hedge
accounting standard.
Board of Governors of the Federal Reserve
System, October 2, 2020.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2020–22275 Filed 10–7–20; 8:45 am]
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than November 9, 2020.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Northwood Financial Services
Corporation, Northwood, Iowa; to
acquire Titonka Savings Bank, Titonka,
Iowa.
Board of Governors of the Federal Reserve
System, October 5, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–22324 Filed 10–7–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6210–01–P
khammond on DSKJM1Z7X2PROD with NOTICES
Food and Drug Administration
FEDERAL RESERVE SYSTEM
[Docket No. FDA–2020–D–1553]
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Premenopausal Women With Breast
Cancer: Developing Drugs for
Treatment; Draft Guidance for
Industry; Availability
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
exposure draft or ASU associated with this project
has been issued.
20 See 83 FR 945–946 (January 8, 2018).
VerDate Sep<11>2014
17:48 Oct 07, 2020
Jkt 253001
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
63559
guidance for industry entitled
‘‘Premenopausal Women with Breast
Cancer: Developing Drugs for
Treatment.’’ This draft guidance
provides recommendations regarding
the inclusion of premenopausal women
in breast cancer clinical trials. The
guidance is intended to assist
stakeholders, including sponsors and
institutional review boards, responsible
for the development and oversight of
clinical trials for breast cancer drugs.
DATES: Submit either electronic or
written comments on the draft guidance
by December 7, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
E:\FR\FM\08OCN1.SGM
08OCN1
]]>Agencies
[Federal Register Volume 85, Number 196 (Thursday, October 8, 2020)]
[Notices]
[Page 63559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22324]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The public portions of the applications listed below, as well as
other related filings required by the Board, if any, are available for
immediate inspection at the Federal Reserve Bank(s) indicated below and
at the offices of the Board of Governors. This information may also be
obtained on an expedited basis, upon request, by contacting the
appropriate Federal Reserve Bank and from the Board's Freedom of
Information Office at https://www.federalreserve.gov/foia/request.htm.
Interested persons may express their views in writing on the standards
enumerated in the BHC Act (12 U.S.C. 1842(c)).
Comments regarding each of these applications must be received at
the Reserve Bank indicated or the offices of the Board of Governors,
Ann E. Misback, Secretary of the Board, 20th Street and Constitution
Avenue NW, Washington, DC 20551-0001, not later than November 9, 2020.
A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant
Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:
1. Northwood Financial Services Corporation, Northwood, Iowa; to
acquire Titonka Savings Bank, Titonka, Iowa.
Board of Governors of the Federal Reserve System, October 5,
2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020-22324 Filed 10-7-20; 8:45 am]
BILLING CODE P
